Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/THERAVANCE-BIOPHARMA-INC-16501278/news/Theravance-Biopharma-Highlights-Positive-Headline-Results-from-IMPACT-Study-of-Trelegy-Ellipta-Ann-25150279/?utm_source=whatsapp&utm_medium=social&utm_campaign=share